RESEARCHER PROFILE
Professor Divya Mehta, Principal Research Fellow
Stress Genomics Laboratory, School of Biomedical Sciences
QUT (Queensland University of Technology), Australia
Understanding the interaction between genes and lifestyle factors in response to stress can lead to potential therapeutic interventions for stress-related disorders. This research is crucial for promoting health and well-being.
Professor Divya Mehta works as a Principal Research Fellow at the Stress Genomics Laboratory, in QUT (Queensland University of Technology) in Australia, specialising in stress genomics and mental health. Her education started in the UK with undergraduate and Masters, followed by her PhD in Germany and postdoctoral at Max Planck Institute of Psychiatry. 11 years ago Professor Mehta moved to Australia.
Her focus is research is understanding how genes and lifestyle factors interact to drive our response to stress, particularly in emergency responders, veterans, and elite athletes, with a focus on epigenetics.
Epigenetics are the dynamic part of our DNA, that change across our lifetime in response to stress, exercise, social support, and nutrition, impacting our overall health.
Social support can reduce and reverse negative impacts of stress on genes, leading to potential therapeutic interventions for stress-related disorders.
Research at the intersection of statistics, genomics, and mental health can provide valuable insights into the devastating impact of mental health disorders on individuals, families, and communities.
Professor Mehta has recently commenced research into elite athlete physical and mental health impact performance, with research at the intersection of statistics, genomics, and mental health. This research is ahead of, and in anticipation of, the Summer Olympics in Brisbane in 2032.
Understanding the drivers of health and well-being is crucial for ensuring a happy and healthy life, which is Professor Mehta’s passion. Outside of the work environment, she also enjoys sports, volunteering for animal rescue, and spending time with family.
-
DNA repair on the Fanconi anaemia pathway
Associate Professor Wayne Crismani is an internationally recognised expert in DNA repair, with a particular focus on Fanconi anaemia (FA)—a cancer-predisposition and bone marrow failure syndrome marked by extreme sensitivity to DNA damage. Based at St Vincent’s Institute in Melbourne, he leads a research program dedicated to understanding the genetic, cellular, and reproductive consequences of FA. He is currently supported by a Victorian Cancer Agency Mid-Career Fellowship and funding from the National Health and Medical Research Council.
-
Peripheral intravenous catheter management
Dr Grace Xu is a clinician-researcher, senior nurse practitioner, and emerging implementation scientist with more than 16 years of emergency nursing experience. She is a Fellow of the College of Emergency Nurses Australasia and a Centaur Fellow. She also leads the Early Career Researcher/Clinician Researcher portfolio within the Alliance for Vascular Access Teaching and Research group.
-
Oral administration of insulin for Type 1 Diabetes
Huiwen Pang is a 3rd year PhD candidate in the Australian Institute for Bioengineering and Nanotechnology, University of Queensland, focusing on biomedical health research. Prior to commencing his PhD, Huiwen studied animal genetics in his Masters degree at Huazhong Agriculture University in China.
People with diabetes, especially Type 1 diabetes, largely rely on the insulin injections or insulin pumps to control their high blood glucose levels, which is painful and has a high risk of infections.
Huiwen Pang is conducting research on nano-based drug formulations for Type 1 diabetes treatment, with a focus on using nanomaterials to load insulin for oral administration and employing anti-apoptotic and anti-inflammatory approaches to mitigate damage to beta cells.
